Monitor website for venue info, Beijing,China
Oct 18 2010 8:00AM - Oct 20 2010 5:00PM
American College of Toxicology Study Director
There has been rapid growth in the contract research organization (CRO) industry over the last several years with much of that growth occurring in China. There is an increasing demand for trained, professional and technical staff s in China to conduct of toxicology and safety studies necessary to meet the regulatory requirements for pharmaceuticals, commodity chemicals, etc. Therefore, the industrial sectors have been hesitant to place studies in China in spite of the generally lower costs for conducting studies in China. This workshop will provide attendees with the details of conducting and supervising toxicology studies in an ever-increasing stringent regulatory environment. The content of this workshop is provided in the tentative outline but the course will include topics on Good Laboratory Practice regulations, study protocol development, species selection, in-life study evaluation, pathology and clinical pathology evaluations, etc.
Although this workshop is directed towards early-career toxicologists and related professional in the CRO industry, this course would be valuable to a broad range of nonclinical, clinical, management and regulatory personnel in pharmaceutical, medical device, biotechnology, commodity chemical and other industrial sector companies. Regulatory and managerial personnel will gain a thorough working knowledge of preclinical development to facilitate planning, project management and creation of efficient development and regulatory strategies.